Tradestie Institutional Equity Comparison Engine

SYK vs DXCM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DXCM Overall Edge

DXCM Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DexCom, Inc. (DXCM) driven by superior Valuation, Growth & Margin, Momentum & Technical while SYK counters with relative strength in Options & Structure. Fundamentally, SYK trades at 19.0x Forward P/E with 24.0% operating margin (+7.6% YoY revenue) versus DXCM at 26.6x Forward P/E and 24.0% operating margin (+11.2% YoY). In options structure, SYK sits in SURGE (5th %ile IV; Dealer Gamma Walls on Pro) against DXCM sits in CONSOLIDATION (9th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner DXCM
SYK 19.0x vs DXCM 26.6x Fwd P/E
Growth & Margin Winner DXCM
Op Margin 24.0% vs 24.0% ยท YoY +7.6% vs +11.2%
Momentum & Technical Winner DXCM
1Y -16.8% vs +36.6% ยท 52W Pos 36% vs 69%
Options & Structure Winner SYK
SURGE (5th %ile IV) vs CONSOLIDATION (9th %ile IV)
SYK NYSE
Stryker Corporation
Surgical & Medical Instruments & Apparatus
$310.79
+0.37% 1D
Market Cap $118.9B
1M Return +5.47%
1Y Return -16.77%
Forward P/E 19.0x
Unified AI Score
46.5 / 100 HOLD
Tech 37.0 Fund 49.0 Flow 58.0 Mom 60.0
DXCM NASDAQ
DexCom, Inc.
Surgical & Medical Instruments & Apparatus
$81.58
-2.11% 1D
Market Cap $30.4B
1M Return -5.19%
1Y Return +36.6%
Forward P/E 26.6x
Unified AI Score
53.8 / 100 HOLD
Tech 74.0 Fund 67.0 Flow 68.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SYK -16.77% DXCM +36.6% Spread: +53.37 pp (DXCM Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SYK Revenue DXCM Revenue SYK Op. Margin DXCM Op. Margin Margin Edge
FY2018 $13.6B $1.03B 18.7% -18.1% SYK
FY2019 $14.9B $1.48B 18.2% 9.6% SYK
FY2020 $14.3B $1.93B 15.5% 15.5% Tie
FY2021 $17.1B $2.45B 15.1% 10.9% SYK
FY2022 $18.4B $2.91B 15.4% 13.4% SYK
FY2023 $20.5B $3.62B 19.0% 16.5% SYK
FY2024 $22.6B $4.03B 16.3% 14.9% SYK
FY2025 $25.1B $4.66B 19.5% 19.6% DXCM

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SYK (2) vs DXCM (7)
Institutional Metric SYK DXCM Criterion Row Winner
Market Capitalization Scale $118.9B $30.4B Larger Scale SYK
Trailing P/E Ratio Valuation 33.3x 32.0x Lower Multiple DXCM
Forward P/E Ratio Valuation 19.0x 26.6x Lower Multiple SYK
Revenue Growth (YoY) Growth +7.6% +11.2% Higher Growth DXCM
Operating Margin (TTM) Profitability 24.0% 24.0% Higher Margin Tie
Net Profit Margin Profitability 13.8% 19.4% Higher Margin DXCM
Return on Equity (ROE) Capital Efficiency 16.0% 37.7% Higher ROE DXCM
52-Week Range Position Momentum 36% ($267โ€“$389) 69% ($57โ€“$93) Stronger Trend DXCM
Beta / 30D Volatility Risk Regime 0.22ฮฒ ยท 50% Vol 0.61ฮฒ ยท 49% Vol Lower Realized Risk DXCM
Unified Institutional Score Composite Signal 46.5 / 100 (HOLD) 53.8 / 100 (HOLD) Higher Composite DXCM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SYK vs DXCM Buy Guide
SYK SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live SYK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DXCM CONSOLIDATION
69d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live DXCM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SYK nor DXCM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.